Delta-24-RGD
Showing 1 - 25 of >10,000
Brain Cancer, Brain Tumor, Glioma Trial in Canada, United States (DNX-2401, pembrolizumab)
Completed
- Brain Cancer
- +10 more
- DNX-2401
- pembrolizumab
-
Little Rock, Arkansas
- +14 more
Jul 13, 2021
Brain Cancer, CNS Diseases Trial in Houston (DNX-2401, Tumor Removal)
Completed
- Brain Cancer
- Central Nervous System Diseases
- DNX-2401
- Tumor Removal
-
Houston, TexasUT MD Anderson Cancer Center
Jul 12, 2018
DLBCL, High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements, High Grade B-Cell Lymphoma w/MYC, BCL2 & BCL6
Recruiting
- Diffuse Large B-Cell Lymphoma
- +2 more
- Prednisone
- +6 more
-
Tampa, Florida
- +1 more
Jan 12, 2022
Pathological Angiogenesis Trial in Lausanne (68Ga-NODAGA-RGD PET/CT, 18F-FDG PET/CT, 18F-FET PET/CT)
Recruiting
- Pathological Angiogenesis
- 68Ga-NODAGA-RGD PET/CT
- +2 more
-
Lausanne, Vaud, SwitzerlandCentre Hospitalier Universitaire Vaudois, Nuclear Medicine
Jun 11, 2022
18F-FAPI-RGD in Interstitial Lung Disease Associated With
Recruiting
- Interstitial Lung Disease
-
Chengdu, Sichuan, ChinaSichuan Provincial People's Hospital
Nov 21, 2023
Renal Tumor Trial
Not yet recruiting
- Renal Tumor
- (no location specified)
Aug 2, 2023
Breast Tumors Trial
Not yet recruiting
- Breast Tumors
- (no location specified)
Aug 2, 2023
Rheumatoid Arthritis Trial
Not yet recruiting
- Rheumatoid Arthritis
- (no location specified)
Jul 6, 2023
Geriatric Depression Trial in Chengde (CBRM (community-based rehabilitation management), TAR(treatment as routine))
Not yet recruiting
- Geriatric Depression
- CBRM (community-based rehabilitation management)
- TAR(treatment as routine)
-
Chengde, Hebei, ChinaChengde Medical University
Nov 3, 2022
NSCLC Trial (KB-GDT-01)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- KB-GDT-01
- (no location specified)
Sep 29, 2023
Squeaking in Ceramic-on-Ceramic Total Hip Arthroplasty Using
Recruiting
- Osteoarthritis, Hip
- +4 more
- Total hip arthroplasty with Delta TT cup
-
Seongnam, Gyeonggi-do, Korea, Republic ofSeoul National University Bundang Hospital
Oct 24, 2022
Chronic Hepatitis Delta Virus Infection Trial (HH-003(20mg/kg), HH-003(10mg/kg), TAF)
Not yet recruiting
- Chronic Hepatitis Delta Virus Infection
- HH-003(20mg/kg)
- +2 more
- (no location specified)
May 7, 2023
Interventions on Admissional SOFA Score on Clinical Outcomes of
Not yet recruiting
- Critically Ill Patients
- Standardized interventions
- (no location specified)
Mar 29, 2023
Tumor Trial in Fuzhou (68Ga-FAP-RGD)
Recruiting
- Tumor
-
Fuzhou, Fujian, ChinaDepartment of Nuclear Medicine, First Affiliated Hospital of Fuj
Aug 23, 2022
Peripheral Artery Disease Trial in Beijing (NL003, Placebo)
Recruiting
- Peripheral Artery Disease
- NL003
- Placebo
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 20, 2023
Tumor, Solid, Positron-Emission Tomography Trial in Xiamen (18F-FDG PET/CT, 68Ga-FAPI-RGD PET/CT)
Recruiting
- Tumor, Solid
- Positron-Emission Tomography
- 18F-FDG PET/CT, 68Ga-FAPI-RGD PET/CT
-
Xiamen, Fujian, ChinaThe First Affiliated Hospital of Xiamen University
Sep 16, 2022
Tumors Trial in Chengdu
Recruiting
- Neoplasms
-
Chengdu, Sichuan, ChinaDepartments of Nuclear Medicine, Sichuan Provincial People's Hos
Oct 16, 2023
Pain, Tolerance, Oral vs Vaporized THC, Abuse Liability Trial in West Haven (Dronabinol 5 MG, Dronabinol 10 MG, 2mg Purified THC
Not yet recruiting
- Pain, Tolerance
- +2 more
- Dronabinol 5 MG
- +4 more
-
West Haven, ConnecticutVA Connecticut Healthcare System
Jun 15, 2023
Chronic Hepatitis Delta Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (Peginterferon
Not yet recruiting
- Chronic Hepatitis Delta
- Peginterferon Lambda
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 25, 2023
Titanium Modular Revision Hip System, With Review of Metal Ion
Not yet recruiting
- Hip Surgery
- x-ray
- (no location specified)
Sep 11, 2023
Cervical Cancer, Head and Neck Squamous Cell Carcinoma, NSCLC Trial in Boston, Saint Louis (ITIL-168)
Withdrawn
- Cervical Cancer
- +2 more
- ITIL-168
- (no location specified)
Dec 16, 2022
MIS-C and Other Complications Following SARS-CoV-2 Infection
Recruiting
- SARS CoV 2 Infection
- +3 more
-
Copenhagen, DenmarkCopenhagen University Hospital Rigshospitalet
Jun 14, 2022
Rotator Cuff Arthropathy or Degeneration of the Glenohumeral Joint With Severe Posterior Wear Trial in Hellerup (Reverse
Recruiting
- Rotator Cuff Arthropathy or Degeneration of the Glenohumeral Joint With Severe Posterior Wear
- Reverse shoulder arthroplsaty
-
Hellerup, DenmarkHerlev and Gentofte Hospital
Aug 2, 2022